(Q28189095)
English
Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections
scientific article (publication date: December 2003)
- Revised Indications for the Use of Palivizumab and Respiratory Syncytial Virus Immune Globulin Intravenous for the Prevention of Respiratory Syncytial Virus Infections
Statements
Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections (English)
0 references
Revised Indications for the Use of Palivizumab and Respiratory Syncytial Virus Immune Globulin Intravenous for the Prevention of Respiratory Syncytial Virus Infections (English)
1 reference
December 2003
0 references
1 December 2003
1 reference
1 reference
112
1 reference
6 Pt 1
0 references
6
1 reference
1442-6
0 references
1442-1446
1 reference